Skip to main content

Cerevel Therapeutics Hldg Inc(CERE-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Cerevel Therapeutics Hldg Inc

222 JACOBS STREET SUITE 200
CAMBRIDGE MA 02141 USA
P: 844-304-2048
http://www.cerevel.com

Profile

Cerevel Therapeutics Inc. treats neuroscience diseases. The company's diversified pipeline comprising clinical-stage investigational therapies and several preclinical compounds to treat neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics Inc., formerly known as Acquisition Corp II, is headquartered in Boston.

Key Executives

NameTitle
Ronald C. RenaudCEO/Director/President
Susan AltschullerCFO
Mark BodenraderChief Accounting Officer/Senior VP, Divisional

More from The Globe